Pan-cancer analysis of NFE2L2 mutations identifies a subset of lung cancers with distinct genomic and improved immunotherapy outcomes
Abstract Background Mutations in the KEAP1-NFE2L2 signaling pathway were linked to increased tumorigenesis and aggressiveness. Interestingly, not all hotspot mutations on NFE2L2 were damaging; some even were activating. However, there was conflicting evidence about the association between NFE2L2 mut...
Príomhchruthaitheoirí: | Kewei Wang, Zixi Li, Ying Xuan, Yong Zhao, Chao Deng, Meidan Wang, Chenjun Xie, Fenglai Yuan, Qingfeng Pang, Wenjun Mao, Dongyan Cai, Zhangfeng Zhong, Jie Mei |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
BMC
2023-10-01
|
Sraith: | Cancer Cell International |
Ábhair: | |
Rochtain ar líne: | https://doi.org/10.1186/s12935-023-03056-9 |
Míreanna comhchosúla
Míreanna comhchosúla
-
Metformin suppresses NFE2L1 pathway activation to inhibit gap junction beta protein expression in NSCLC
de réir: Shuo Yu, et al.
Foilsithe / Cruthaithe: (2024-04-01) -
Multi-Omics Analysis of Molecular Characteristics and Carcinogenic Effect of NFE2L3 in Pan-Cancer
de réir: Mengxiao Liu, et al.
Foilsithe / Cruthaithe: (2022-06-01) -
Functional Polymorphism in the NFE2L2 Gene Associated With Tuberculosis Susceptibility
de réir: Guiyi Ji, et al.
Foilsithe / Cruthaithe: (2021-05-01) -
NFE2L1/Nrf1 serves as a potential therapeutical target for neurodegenerative diseases
de réir: Kamila Łuczyńska, et al.
Foilsithe / Cruthaithe: (2024-02-01) -
The roles of NFE2L1 in adipocytes: Structural and mechanistic insight from cell and mouse models
de réir: Suping Ren, et al.
Foilsithe / Cruthaithe: (2021-08-01)